MedPath

Proof-of-Concept Study Assessing VNS Paired With Tones for Tinnitus

Not Applicable
Completed
Conditions
Severe Tinnitus
Interventions
Device: vagus nerve stimulation (VNS)
Registration Number
NCT01253616
Lead Sponsor
MicroTransponder Inc.
Brief Summary

This is a proof-of-concept study designed to provide feasibility information on the clinical use of vagus nerve stimulation (VNS) paired with tones for the treatment of severe tinnitus. The study is expected to give preliminary efficacy and safety information.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • 18 to 65 years of age
  • Diagnosed with subjective tinnitus due to hearing loss with at least some tonal quality of the tinnitus.
  • Diagnosis of tinnitus for at least one year
  • Tinnitus severity of 18 or greater on TRQ cross checked with TQ severity of Grade 3 or worse

Key

Exclusion Criteria
  • Acute or intermittent tinnitus
  • Severe hearing loss
  • History of significant ear disease such as Meniere's disease, ear tumors, or evidence of active middle ear disease.
  • Any other implanted device

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
VNS plus tonesvagus nerve stimulation (VNS)-
Primary Outcome Measures
NameTimeMethod
Audiometric measurementsweekly through one month
Secondary Outcome Measures
NameTimeMethod
tinnitus questionairesweekly through one month
adverse eventsas they occur

Trial Locations

Locations (1)

University Hospital Antwerp

🇧🇪

Antwerp, Edegem, Belgium

© Copyright 2025. All Rights Reserved by MedPath